CE Hours: 1.5
Seq# 64 - Precision Oral Oncology: A Head and Neck Cancer Perspective
This session will be recorded and available through IADR CE On Demand after the meeting for Continuing Education Credit.
Head and neck cancers (HNC) are diverese and the most common squmaous cell carcinoma (over 90%) has been treated with traditional methods such as surgery, radiation therapy and limited chemotherapeutic interventions. There is hope with a new concept of ‘precision oral oncology’, an approach to personalized medicine where genetic and other alterations of both patient and tumour are taken into consideration for potential prevention, early detection and management. This symposium is aimed at reviewing the current knowldege and available methodolgies and potential interventions in HNC. A panel of experienced senior researchers, pathologists and clinicians in the field of oral oncology will address the above aspects and the role of precison oral oncology in personalised medicine.
- Provide a comprehensive update on precision medicine and oral oncology
- Highlight diagnostic, prognostic, and potential therapeutic implications of current knowledge on head and neck cancer with special reference to squamous cell carcinoma
- Stimulate thoughts on additional strategies and directions of future inquiries in the field
1:50 pm–2:10 pm 25 July (Europe - London)
2:10 pm–2:30 pm 25 July (Europe - London)
2:30 pm–2:50 pm 25 July (Europe - London)